Blog
Spexis provides business update and announces financial results for the first half of 2023
Spexis provides business update and announces financial results for the first half of 2023
Ørsted completes 200 MW wind farm in Kansas
Ørsted completes 200 MW wind farm in Kansas
ESG Report shows status quo and outlines path for future sustainability improvements Media Release Zurich, September 29, 2023
ESG Report shows status quo and outlines path for future sustainability improvements
Media Release
Zurich, September 29, 2023
Thalassa Holdings Ltd: Amendment to Articles of Association
Thalassa Holdings Ltd: Amendment to Articles of Association
EQS-News: PANTAFLIX AG with production-driven revenue growth in the first half of 2023
EQS-News: PANTAFLIX AG with production-driven revenue growth in the first half of 2023
Renewi plc: Further response to possible offer announcement by Macquarie Asset Management (“Macquarie”)
Renewi plc: Further response to possible offer announcement by Macquarie Asset Management (“Macquarie”)
IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V.
IGEA Pharma N.V.: Convening notice and Agenda “Annual Shareholder Meeting” IGEA Pharma N.V.
New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
Commerzbank has decided on new Capital Return Policy
Commerzbank has decided on new Capital Return Policy
EQS-News: New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
EQS-News: New Capital Return Policy decided: Commerzbank plans to increase shareholder participation in company’s success
EQS-Adhoc: Commerzbank has decided on new Capital Return Policy
EQS-Adhoc: Commerzbank has decided on new Capital Return Policy
Kaufman & Broad SA: FITCH RATING CONFIRMS KAUFMAN & BROAD'S RATING
Kaufman & Broad SA: FITCH RATING CONFIRMS KAUFMAN & BROAD'S RATING
EQS-News: cyan AG publishes interim report for the first half of 2023
EQS-News: cyan AG publishes interim report for the first half of 2023
Affluent Medical : H1 2023 results. Major advances in clinical programs. Extension of cash horizon to February 2024.
Affluent Medical : H1 2023 results. Major advances in clinical programs. Extension of cash horizon to February 2024.
EQS-News: Affluent Medical SA: H1 2023 RESULTS - Major advances in clinical programs - Extension of cash horizon to February 2024
EQS-News: Affluent Medical SA: H1 2023 RESULTS - Major advances in clinical programs - Extension of cash horizon to February 2024
Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap
Travis Perkins: Director/PDMR Shareholding
Travis Perkins: Director/PDMR Shareholding
Hardman & Co Research on Surface Transforms (SCE): Interim results
Hardman & Co Research on Surface Transforms (SCE): Interim results
EQS-News: ElringKlinger appoints Thomas Jessulat as CEO and names Dirk Willers as a new member of the Management Board
EQS-News: ElringKlinger appoints Thomas Jessulat as CEO and names Dirk Willers as a new member of the Management Board
EQS-News: Aareal Bank launches dedicated team for alternative living financing
EQS-News: Aareal Bank launches dedicated team for alternative living financing
Renewi plc: Response to possible offer announcement by Macquarie
Renewi plc: Response to possible offer announcement by Macquarie
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
EQS-News: Mynaric passes major product milestone of CONDOR Mk3, completing verification and interoperability tests
EQS-News: Mynaric passes major product milestone of CONDOR Mk3, completing verification and interoperability tests
Renewi plc: Holding(s) in Company
Renewi plc: Holding(s) in Company


